The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Khamaganova I.V.

Russian State Medical University, Moscow

Lomakina E.A.

Moskovskiĭ nauchno-prakticheskiĭ tsentr dermatovenerologii i kosmetologii Departamenta zdravookhraneniia Moskvy

Kashevarov D.F.

FUV RNIMU im. N.I. Pirogova

Fedorova Iu.S.

Moskovskiĭ nauchno-prakticheskiĭ tsentr dermatovenerologii i kosmetologii Departamenta zdravookhraneniia Moskvy

Topical therapy algorithm in children with atopic dermatitis

Authors:

Khamaganova I.V., Lomakina E.A., Kashevarov D.F., Fedorova Iu.S.

More about the authors

Read: 1042 times


To cite this article:

Khamaganova IV, Lomakina EA, Kashevarov DF, Fedorova IuS. Topical therapy algorithm in children with atopic dermatitis. Russian Journal of Clinical Dermatology and Venereology. 2013;11(6):95‑99. (In Russ.)

Recommended articles:
Infe­ctious factors in atopic dermatitis, pharmaceutical possibilities (systematic lite­rature review). Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):7-15
Search of diagnostic and prognostic biomarkers of immu­noinflammatory dermatoses by means of flow cyto­metry. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):170-177
Nucleotide sequence variants in IL4 and TNFA genes in patients with dermatoses and xero­sis. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):178-184
Asse­ssment of the serum inte­rleukin 33 (IL-33) level in patients with atopic dermatitis. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(3):293-296
Gene­sis of emollients. Past, present, future. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):412-420
From atopy to infe­ction — a clinical case of combined skin pathology. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):430-436
Atopic dermatitis: the problem of adhe­rence to emollients. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(5):698-707
Mechanisms of addi­tivity of physiotherapeutic factors in complex therapy of poly­pous rhinosinusitis complicated by como­rbidities. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2025;(3):5-11

References:

  1. Dermatovenerologiya. Natsional'noe rukovodstvo. Pod red. Yu.K. Skripkina, Yu.S. Butova, O.L. Ivanova. M: GEOTAR-Media 2011.
  2. Carbone A., Siu A., Patel R. Pediatric atopic dermatitis: a review of the medical management. Ann Pharmacother 2010; 44: 1448-1458.
  3. Akdis C.A., Akdis M., Bieber T., Bindslev-Jensen C., Boguniewicz M., Eigenmann P., Hamid Q., Kapp A., Leung D.Y., Lipozencic J., Luger T.A., Muraro A., Novak N., Platts-Mills T.A., Rosenwasser L., Scheynius A., Simons F.E., Spergel J., Turjanmaa K., Wahn U., Weidinger S., Werfel T., Zuberbier T. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol 2006; 118: 1: 152-169.
  4. Luger T.A. Balancing efficacy and safety in the management of atopic dermatitis: the role of methylprednisolone aceponate. J Eur Acad Dermatol Venerol 2011; 25: 251-258.
  5. Blume-Peytavi U., Wahn U. Optimizing the treatment of atopic dermatitis in children: a review of the benefit/risk ratio of methylprednisolone aceponate. J Eur Acad Dermatol Venerol 2011; 25: 508-515.
  6. Schmitt J., Von Kobyletzky I., Svensson A. et al. Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized, controlled trials. Br J Dermatol 2011; 164: 415-428.
  7. Blume-Peytavi U., Metz M. Atopic dermatitis in children: management of pruritis. J Eur Acad Dermatol Venerol 2012; 26: Suppl 6: 2-8.
  8. Kulagin V.I., Khamaganova I.V., Voinich Z.V., Shekrota A.G. Opyt primeneniya mazi "Advantan" v detskoi dermatologicheskoi praktike. Vestn dermatol i venerol 2000; 6: 50.
  9. Machado S. Effective use of methylprednisolone aceponate 0,1% in a 9-month-old infant with atopic eczema and sleep disturbance. J Eur Acad Dermatol Venerol 2012; 26 (Suppl 6): 14-15.
  10. Torrelo A. Successful treatment of widespread eczema and sleep disruption in a 7-month-old infant with methylprednisolone aceponate 0,1%. J Eur Acad Dermatol Venerol 2012; 26: Suppl 6: 16-17.
  11. Bieber T., VickK., Fölster-Holst R., Belloni-Fortina A., Städtler G., Worm M., Arcangeli F. Efficacy and safety of methylprednisoloneaceponate 0,1% compared to tacrolimus 0,03% in children and adolescents with an acute flare of severe atopic dermatitis. Allergy 2007; 62: 184-189.
  12. Khamaganova I. Alleviation of a severe pruritic flare-up in a 13-year-old child with chronic atopic dermatitis treated with methylprednisolone aceponate 0,1%. J Eur Acad Dermatol Venerol 2012; 26: Suppl 6: 20-21.
  13. Peserico A., Städtler G., Sebastian M. et al. Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient:a multicenter, randomized, double-blind, control study. Br J Dermatol 2008; 158: 801-807.
  14. Torrelo A. Methylprednisolone aceponate 0,1% in the treatment of pruritic lichenified eczema in a 3-year-old child with chronic atopic dermatitis. J Eur Acad Dermatol Venerol 2012; 26: Suppl 6: 16-17.
  15. Kokhan M.M., Kenikfest Yu.V., Novikov G.M. Effektivnost' sochetannogo primeneniya naruzhnykh sredstv terapii i uvlazhneniya kozhi u bol'nykh atopicheskim dermatitom. Vestn dermatol i venerol 2007; 4: 50.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.